Clinical Trial Update: Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating bevacizumab and temsirolimus alone or with valproic acid or cetuximab in patients with advanced or metastatic malignancies, including C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Castleman Disease
• Digestive System Cancer
• Lymphangioleiomyomatosis
• Malignant Neoplasm
• Pharyngeal Cancer
• Soft Tissue Sarcoma
• Thyroid Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Cetuximab (cetuximab)
• Temsirolimus (temsirolimus)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Malignant Neoplasm, Castleman Disease | Phase 1 | Status: ACTIVE_NOT_RECRUITING